![Elizabeth Yamashita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Elizabeth Yamashita worked as a Group Director-Global Regulatory Sciences & CMC at Bristol Myers Squibb Co. from 2000 to 2006.
She then worked as a Vice President-Regulatory CMC & Operations at ImClone LLC from 2006 to 2011.
From 2011 to 2012, she worked as a Vice President-CMC Regulatory at Savient Pharmaceuticals, Inc. She then worked as a Group Vice President-Regulatory Affairs at Savient Pharmaceuticals, Inc. from 2012 to 2014.
Finally, she worked as a Vice President-Regulatory Affairs at Outlook Therapeutics, Inc. Ms. Yamashita received an undergraduate degree from the University of Rochester.
Eerdere bekende functies van Elizabeth Yamashita
| Bedrijven | Functie | Einde |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01-01-2014 |
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01-10-2012 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01-06-2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2006 |
| OUTLOOK THERAPEUTICS, INC. | Algemeen Adviseur | - |
Opleiding van Elizabeth Yamashita
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
